Skip to main content
Welcome to
super saver spring
offer ends april 20
save over $140
Sale ends in
$0.99
per week for 24 weeks
Welcome to
super saver spring
$0.99
per week for 24 weeks
save over $140
// //

Bayer is seeking to end legal disputes it inherited with its $63-billion takeover of Monsanto in 2018.

Mike Blake/Reuters

Bayer was forced on Wednesday to delay part of a proposed settlement of allegations that its widely used weedkiller Roundup caused cancer after a U.S. judge questioned its plan to deal with future claims.

The German company said that lawyers representing those preparing a class action had withdrawn a request for court approval of the US$1.25-billion future claims scheme, part of a broader US$10.9-billion agreement to settle close to 100,000 U.S. lawsuits related to Roundup.

The move would give both sides more time to address questions raised by Federal District Court Justice Vince Chhabria of the Northern District of California who presides over the federal Roundup litigation, Bayer said.

Story continues below advertisement

Justice Chhabria had raised concerns over Bayer’s plan to create an independent panel of scientific experts to help assess whether glyphosate-based weedkillers such as Roundup caused cancer.

“Bayer remains strongly committed to a resolution that simultaneously addresses both the current litigation on reasonable terms and a viable solution to manage and resolve potential future litigation,” the company statement said.

Bayer said the wider agreement to settle current claims at a cost of up to US$9.6-billion was not affected by Wednesday’s decision, which only affected the agreement on future claims.

It declined to comment on the impact on the timetable for the bulk of the settlement.

“The [withdrawal] decision means that Bayer is back to square one when it comes to managing future claims, which will be worked up and filed over the coming years,” said David Noll, a law professor at Rutgers University who closely follows the litigation.

Elizabeth Cabraser, a lawyer representing the lead plaintiffs in the negotiations, said lawyers remained strongly committed to a fair and just resolution for all cases not yet included in the wider settlement.

Bayer is seeking to end legal disputes it inherited with its US$63-billion takeover of Monsanto in 2018.

Story continues below advertisement

COURT SNAG

On Tuesday, Bayer shares had fallen more than 6 per sent after Justice Chhabria said that the court was inclined to oppose the part of the proposed settlement that deals with future claims. The case was due to be considered again on July 24.

The shares slipped 0.7 per cent on Wednesday.

The company on Wednesday declined to say whether it would continue pursuing the idea of an outside scientific panel and said it would make adjustments to its existing plan to address Justice Chhabria’s questions.

The San Francisco-based federal judge in a filing on July 6 had questioned the idea of delegating the decision from judges and juries to a panel of scientists.

Justice Chhabria also questioned whether potential claimants would want to remain bound by a ruling reached by the proposed scientific panel if research is still continuing.

Regulators including the U.S. Environmental Protection Agency and the European Chemicals Agency, have determined glyphosate to be non-carcinogenic, supporting Bayer’s claim that the active ingredient in its Roundup product is safe for agricultural use.

Story continues below advertisement

However, in 2015, the World Health Organization’s cancer research arm determined the herbicide to be a “probable carcinogen,” and since 2018, three consecutive U.S. juries, who listened to scientific evidence from both sides during trials, found that Roundup causes cancer.

Be smart with your money. Get the latest investing insights delivered right to your inbox three times a week, with the Globe Investor newsletter. Sign up today.

Your Globe

Build your personal news feed

  1. Follow topics and authors relevant to your reading interests.
  2. Check your Following feed daily, and never miss an article. Access your Following feed from your account menu at the top right corner of every page.

Follow topics related to this article:

View more suggestions in Following Read more about following topics and authors
Report an error
Due to technical reasons, we have temporarily removed commenting from our articles. We hope to have this fixed soon. Thank you for your patience. If you are looking to give feedback on our new site, please send it along to feedback@globeandmail.com. If you want to write a letter to the editor, please forward to letters@globeandmail.com.

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff.

We aim to create a safe and valuable space for discussion and debate. That means:

  • Treat others as you wish to be treated
  • Criticize ideas, not people
  • Stay on topic
  • Avoid the use of toxic and offensive language
  • Flag bad behaviour

If you do not see your comment posted immediately, it is being reviewed by the moderation team and may appear shortly, generally within an hour.

We aim to have all comments reviewed in a timely manner.

Comments that violate our community guidelines will not be posted.

UPDATED: Read our community guidelines here

Discussion loading ...

To view this site properly, enable cookies in your browser. Read our privacy policy to learn more.
How to enable cookies